Please read this notice carefully - It applies to all persons who view this site
These materials are not directed at or intended to be accessed by persons located outside India. These materials are being made available on this website to comply with Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended.
Investors should read the Addendum to the DRHP (as defined below) and seek professional advice before taking any action.
Important : You must read and agree with the terms and conditions of the following disclaimer before continuing.
The following disclaimer applies to the addendum dated August 13, 2026 (“Addendum”) to the draft red herring prospectus dated January 19, 2026 (“DRHP”) of EAAA India Alternatives Limited (the “Company”) filed with the Securities and Exchange Board of India (the “SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) hosted on this website in connection with the proposed initial public offering of equity shares of face value of ₹ 5 each (“Equity Shares”) of the Company, by way of an offer for sale of Equity Shares (the “Offer”). The Addendum has been made available on this website in electronic form solely to comply with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”). You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Addendum. By accessing the Addendum, you agree to follow the following terms and conditions, including any modifications to them from time to time.
The contents of the Addendum are for your information only and you acknowledge that access to the Addendum is intended for use by you only and you agree not to forward the Addendum on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents herein shall be copied or duplicated in any form by any means or redistributed. Any person into whose possession the Addendum comes is required to inform himself or herself about and to observe any such restrictions. The Addendum does not amount to, or is intended to be, a prospectus or an offer document, in terms of the Companies Act, 2013, and the SEBI ICDR Regulations, and nothing in the Addendum constitutes an offer or an invitation by or on behalf of either the Company, the Selling Shareholders or any of the members of the syndicate to subscribe for or purchase any of the securities described therein. The information contained in the Addendum may not be updated since its original publication date and may not reflect the latest updates. The information is current only as of its date and shall not, under any circumstances, create any implication that the information contained therein is correct as of any time subsequent to the date thereof or that there has been no change in the financial condition or affairs of the Company since such date. This document may be updated from time to time and there is no undertaking by us to post any such amendments or supplements on this website.
Please note that because of restrictions imposed by applicable law or regulation on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. Accordingly, the Offer related information on this site is not available to all jurisdictions. The Addendum is directed at, and is, intended for distribution to, and use by, residents of India only. The Addendum is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where distribution or use of such information would not be permissible under or in violation of any applicable law or regulation.
The Equity Shares have not been recommended by any U.S. federal or state securities commission or regulatory authority. Furthermore, the foregoing authorities have not confirmed the accuracy or determined the adequacy of the Addendum, or approved or disapproved the Equity Shares. Any representation to the contrary is a criminal offence in the United States. In making an investment decision investors must rely on their own examination of our Company and the terms of the Offer, including the merits and risks involved.
Our Company has not registered and does not intend to register under the U.S. Investment Company Act of 1940, as amended (the “U.S. Investment Company Act”) in reliance on Section 3(c)(7) of the U.S. Investment Company Act, and investors will not be entitled to the benefits of the U.S. Investment Company Act. Accordingly, the Equity Shares are only being offered and sold (i) to persons in the United States or to or for the account or benefit of, U.S. Persons, in each case to investors that are both “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act of 1933, as amended (“U.S. Securities Act”) and referred to in the Draft Red Herring Prospectus as “U.S. QIBs” and, for the avoidance of doubt, the term U.S. QIBs does not refer to a category of institutional investor defined under applicable Indian regulations and referred to in the Draft Red Herring Prospectus as “QIBs”) and “qualified purchasers” (as defined under the U.S. Investment Company Act and referred to in the Draft Red Herring Prospectus as “QPs”) in transactions exempt from or not subject to the registration requirements of the U.S. Securities Act and in reliance on Section 3(c)(7) of the U.S. Investment Company Act; or (ii) outside the United States to investors that are not U.S. Persons nor persons acquiring for the account or benefit of U.S. Persons in “offshore transactions” as defined in, and in reliance on, Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur.
Any potential investor should note that investment in the equity shares involves a high degree of risk. For details, potential investors should refer to the red herring prospectus, including the section titled “Risk Factors”, when available. Any decision on whether to invest in the equity shares described in the Addendum and the DRHP may only be made after a red herring prospectus has been filed with the Registrar of Companies, Maharashtra at Mumbai – I (“RoC”), and must be made solely on the basis of the red herring prospectus proposed to be filed with the RoC. Potential investors should not rely on the Addendum or the DRHP filed with SEBI and the Stock Exchanges.
The Company has taken all necessary steps to ensure that the contents of the Addendum as appearing on this website are identical to the Addendum filed with SEBI and the Stock Exchanges. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently we do not accept any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. The Company and the BRLMs cannot and does not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Addendum beyond the date of the Addendum. We will not be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
To access this information, you must confirm by pressing on the button marked “I Confirm” that, at the time of access you are located and resident in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.
The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to subscribe or buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.
